Company news

MaxCyte, Inc. news in 2025

MaxCyte, Inc.'s news releases, calls and decks from 2025, newest first.

View company

MaxCyte Announces Planned CFO Transition in 2026

November 12, 2025

MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance

November 12, 2025

MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance

November 5, 2025

MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025

October 8, 2025

MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors

October 6, 2025

MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability

September 22, 2025

MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

August 6, 2025

MaxCyte Signs Platform License Agreement with Adicet Bio

August 4, 2025

MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline

July 31, 2025

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025

July 9, 2025

PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan

July 1, 2025

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies

June 11, 2025

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance

May 7, 2025

MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025

April 10, 2025

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance

March 11, 2025

MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs

February 11, 2025

MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

January 29, 2025

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

January 12, 2025

Calls in 2025

Decks in 2025